The Worldwide Proton Therapy Industry is Projected to Reach $1.5 Billion by 2031
November 04, 2022 06:33 ET
|
Research and Markets
Dublin, Nov. 04, 2022 (GLOBE NEWSWIRE) -- The "Proton Therapy Market By Indication, By Product Type, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been added...
Outlook on the Proton Therapy Market in the United States to 2027 - Proton Therapy Offers Less Radiation Exposure While Demoting Side Effects
October 20, 2022 05:03 ET
|
Research and Markets
Dublin, Oct. 20, 2022 (GLOBE NEWSWIRE) -- The "United States Proton Therapy Market, Size, Forecast 2022-2027, Industry Trends, Impact of COVID-19, Growth, Opportunity Company Analysis" report has...
Japan Proton Therapy Market to Reach $8.6 Billion by 2027 at a 5.9% CAGR
October 13, 2022 05:08 ET
|
Research and Markets
Dublin, Oct. 13, 2022 (GLOBE NEWSWIRE) -- The "Japan Proton Therapy Market, Share, Forecast 2022-2027, Industry Trends, Growth, Size, Impact of COVID-19, Company Analysis" report has been added to ...
Pancreatic Cancer Treatment Market Size [2022-2029] | Industry Share, Revenue, Key Players, CAGR, Demand and Forecast
September 28, 2022 07:22 ET
|
Fortune Business Insights
Pune, India, Sept. 28, 2022 (GLOBE NEWSWIRE) -- The global pancreatic cancer treatment market size is expected to rise substantially owing to increasing consumption of cigarettes and rising...
$10.8 Billion Worldwide Radiation Oncology Industry to 2027 - Featuring Accuray, Canon, Elekta and Hitachi Among Others
September 28, 2022 04:18 ET
|
Research and Markets
Dublin, Sept. 28, 2022 (GLOBE NEWSWIRE) -- The "Radiation Oncology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Alpha Tau Announces the Acceptance in Major Peer-Reviewed Journals (International Journal of Radiation Oncology, Biology, Physics, and Frontiers in Oncology) of Two Landmark Pre-Clinical Studies Demonstrating Significant Potential Synergies Between the Alpha DaRT Treatment and Standard-of-Care Immunotherapy, Chemotherapy and Anti-Angiogenic Therapy
September 08, 2022 16:05 ET
|
Alpha Tau Medical Ltd.
– Study on combination with anti-PD1 therapy published by International Journal of Radiation Oncology, Biology, Physics, known in the field as the Red Journal, the official journal of the American...
Alpha Tau Appoints Industry Veteran Peter Melnyk as Chief Commercial Officer
September 01, 2022 16:15 ET
|
Alpha Tau Medical Ltd.
JERUSALEM, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that...
Alpha Tau Medical to Participate in Upcoming September Investor Conferences
August 30, 2022 16:05 ET
|
Alpha Tau Medical Ltd.
JERUSALEM, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced the...
Alpha Tau and MIM Software Announce Collaboration for Alpha DaRT Treatment Planning
August 22, 2022 09:00 ET
|
Alpha Tau Medical Ltd.
JERUSALEM and CLEVELAND, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Today, Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, and...
Global Radiotherapy Market Report 2022: Growing Use of Particle Therapy for Cancer Treatment & Awareness Initiatives on the Benefits of Radiotherapy Driving Growth
August 18, 2022 05:53 ET
|
Research and Markets
Dublin, Aug. 18, 2022 (GLOBE NEWSWIRE) -- The "Radiotherapy Market by Type (Product, Service), Technology (LINAC, Stereotactic LINAC, Particle Therapy, Cobalt-60 Teletherapy), Procedure (IMRT, IGRT,...